Followers

December 24, 2023

US FDA declines to approve Zealand Pharma's drug for low blood sugar in Infants

The company is seeking regulatory approval for the use of the drug in patients aged seven days or older with CHI, a genetic disorder in which the insulin cells of the pancreas secrete too much insulin.

No comments:

Post a Comment